NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/11/2023
Voltar para busca
Dado oficial do USPTO
STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO)
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO)
ST13
US500000097163869Classe
35, 42
Pedido
97163869
Registro
7210095
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
07/11/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
09/12/2021
Data de registro
07/11/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/11/2023
Última transação
07/11/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
2009-03-00
Primeiro uso no comércio
2009-03-00
Código do desenho
4
Tipo de titular
16
Localização do titular
Natick, MA, US
Examinador
COUGHLAN, REBECCA D.
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Boston Biotech Clinical Research, LLC
Representantes
Michelle Rosenberg PATENT GC LLC C/O CLARIVATE
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and management in the field of medical and scientific research and development and clinical trials for biotechnologypharmaceuticalmedical device companiesassisting companies with developing business strategies and road maps for medical and scientific research and development; assisting companies in the nature of business advisory services in the field of business plan development for biotechnologypharmaceuticalmedical device companies; assisting companies with trial feasibility in the nature of providing independent review of clinical trials for business purposes; assisting companies with clinical trials compliancein the nature of business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceuticalbiotechnology companies to assist them with clinical researchclinical trialsapplications for drug approval; business concept development and implementation in the field of the pharmaceutical industry; business consulting and management in the field of clinical trialsproviding information management services; business management and development consulting services for clinical research organizations (CRO)drug manufacturersproviding in-house and out-sourced business functions and activitiesoutsourcing services and office administration services; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of biopharmaceutical companies to assist them with clinical researchclinical trialsapplications for drug approval in the fields of geneticsepigeneticbiologics and small molecule therapeuticsdrugscombination drug and device products; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; and assisting companies with developing global regulatory approval strategies and navigating the regulatory submission and approval processall in the nature of regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies
Classe 42
Providing medical and scientific research information in the field of clinical trials; consulting services for others in the field of designplanningimplementation project management of clinical trials
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/08/2023
PUBO
PUBLISHED FOR OPPOSITION
22/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/07/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
18/07/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/07/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
18/07/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/07/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/05/2023
GNFR
FINAL REFUSAL E-MAILED
03/05/2023
CNFR
FINAL REFUSAL WRITTEN
03/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/11/2022
GNRT
NON-FINAL ACTION E-MAILED
16/11/2022
CNRT
NON-FINAL ACTION WRITTEN
16/11/2022
DOCK
ASSIGNED TO EXAMINER
17/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/12/2021
NWAP
NEW APPLICATION ENTERED
13/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO) ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.